Bayesian Capital Management, LP Karyopharm Therapeutics Inc. Transaction History

Bayesian Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.31 $7,548 - $14,541	11,100 New	11,100 $9,000
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $90,192 - $124,491	-31,758 Reduced 72.78%	11,880 $46,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $108,222 - $258,773	43,638 New	43,638 $148,000
Q2 2021 Aug 13, 2021	SELL	$8.11 - $11.11 $218,969 - $299,970	-27,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$9.85 - $17.69 $265,950 - $477,630	27,000 New	27,000 $284,000
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $233,246 - $354,787	-14,051 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $202,053 - $389,493	14,051 New	14,051 $270,000
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $93,223 - $198,667	-10,100 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$5.66 - $11.85 $57,166 - $119,685	10,100 New	10,100 $97,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.